Abstract Library

#4016 Factors influencing emergency admissions in patients with neuroendocrine neoplasms (NEN) in England 2016-2017

Introduction: Diagnostic delays in neuroendocrine neoplasms (NEN) are common, with NENs presenting as emergencies in a subset of cases. Emergency presentations (EP) may cause poor outcomes and should be avoided.

Conference:

Presenting Author: El Asmar M

Authors: El Asmar M, Mortagy M, Chandrakumaran K, Srirajaskanthan R, Ramage J,

Keywords: Neuroendocrine tumor, Emergency admission, Survival analysis,

#3642 GP-patient interactions and coding of neuroendocrine tumors (NETs) in primary care records

Introduction: Diagnostic delays in NETs are common with improved diagnosis times recently shown in Wales. Although studies have explored GP visits, these are based on patient surveys with recall bias and no exploration of GP coded data.

Conference:

Presenting Author: Olive S

Authors: Olive S, Gould H, Navaratnam J, Khan M,

Keywords: diagnosis, GP, primary care, coding,

#3444 Earlier diagnosis of Neuroendocrine Tumors (NETs) through transformation of the South Wales NET Service

Introduction: Neuroendocrine tumors (NETs) are heterogeneous cancers, arising mainly from the gastroenteropancreatic tract. Delayed diagnosis and mislabelling are widely recognised internationally in midgut NETs with little data describing how to improve diagnosis times. In 2017, transformation of the South Wales NET Service included a change to a gastroenterology-led service model, alongside education and forming working relationships with gastroenterologists and surgeons.

Conference:

Presenting Author:

Authors: Gould H, Kapish A, Karategos T, Abbas S, Taylor R,

Keywords: midgut NET, midgut neuroendocrine tumor, diagnosis, diagnostic delay, investigation, mislabel, imaging,

#2775 Glucagonoma: Still a Misleading Disease and the Importance of Multidisciplinary Neuroendocrine Tumor Board

Introduction: Glucagonoma is a rare neuroendocrine tumor (NET) of the pancreatic alpha cells that results in the overproduction of the hormone glucagon. This entity is typically associated with a rash called necrolytic migratory erythema, weight loss and diabetes.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Parlagreco E

Authors: Parlagreco E, La Salvia A, Persano I, Pia A, Scagliotti G,

Keywords: glucagonoma, necrolytic migratory erithema, diagnostic delay, patient’s quality of life,